# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-198515
Filing Date
2018-06-21
Accepted
2018-06-21 06:16:02
Documents
22
Period of Report
2018-06-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | d619694d6k.htm | 6-K | 28619
2 | GRAPHIC | g6196941.jpg | GRAPHIC | 25304
3 | GRAPHIC | g619694txs10g1.jpg | GRAPHIC | 368312
4 | GRAPHIC | g619694txs11g1.jpg | GRAPHIC | 217887
5 | GRAPHIC | g619694txs12g1.jpg | GRAPHIC | 66047
6 | GRAPHIC | g619694txs13g1.jpg | GRAPHIC | 241805
7 | GRAPHIC | g619694txs14g1.jpg | GRAPHIC | 241338
8 | GRAPHIC | g619694txs15g1.jpg | GRAPHIC | 224951
9 | GRAPHIC | g619694txs16g1.jpg | GRAPHIC | 76265
10 | GRAPHIC | g619694txs17g1.jpg | GRAPHIC | 254710
11 | GRAPHIC | g619694txs18g1.jpg | GRAPHIC | 337025
12 | GRAPHIC | g619694txs19g1.jpg | GRAPHIC | 245397
13 | GRAPHIC | g619694txs20g1.jpg | GRAPHIC | 288818
14 | GRAPHIC | g619694txs21g1.jpg | GRAPHIC | 178622
15 | GRAPHIC | g619694txs22g1.jpg | GRAPHIC | 238433
16 | GRAPHIC | g619694txs23g1.jpg | GRAPHIC | 79878
17 | GRAPHIC | g619694txs4g1.jpg | GRAPHIC | 195427
18 | GRAPHIC | g619694txs5g1.jpg | GRAPHIC | 317994
19 | GRAPHIC | g619694txs6g1.jpg | GRAPHIC | 238138
20 | GRAPHIC | g619694txs7g1.jpg | GRAPHIC | 247707
21 | GRAPHIC | g619694txs8g1.jpg | GRAPHIC | 268821
22 | GRAPHIC | g619694txs9g1.jpg | GRAPHIC | 220839
| Complete submission text file | 0001193125-18-198515.txt |  | 6331467

Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 18910849
SIC: 2834 Pharmaceutical Preparations